Home › Down Syndrome › Pennsylvania › Pittsburgh
Down Syndrome clinical trials in Pittsburgh, PA
4 studies for Down Syndrome are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
RecruitingObservational study
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Collaboration for Down Syndrome Progress (CDP)
RecruitingObservational study
- University of Pittsburgh, Pittsburgh
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RecruitingObservational study
- University of Pittsburgh, Co-Enrolling through ABC-DS Only, Pittsburgh
About Down Syndrome
About 1 in 700 babies are born with the birth defect known as Down Syndrome. Learn about the different Down Syndrome types and related health issues.
More about Down Syndrome on MedlinePlus
Down Syndrome trials in other cities
- Aurora, CO7 studies
- Houston, TX6 studies
- Phoenix, AZ6 studies
- Durham, NC6 studies
- Cincinnati, OH5 studies
- Nashville, TN5 studies
- Kansas City, KS5 studies
- Orlando, FL5 studies
- Ann Arbor, MI5 studies
- Philadelphia, PA5 studies
- Cleveland, OH5 studies
- Atlanta, GA4 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.